Taewoo Lim is a 2021 graduate of the LL.M. in National and Global Health Law program.
Prior to Georgetown, Lim worked at the Korean bio pharmaceutical company, Helixmith, which was developing new DNA drug candidates in the U.S. As the leader of the legal team, he led contract reviews and negotiations and managed disputes including lawsuits, arbitrations, and inspections by authorities. Lim was involved in various business transactions, including alliances with other pharmaceutical companies and investors. He also assisted management and other departments in the decision-making and problem-solving processes, both from business and legal perspectives. After being elected as a voting member of the patent committee, he also participated in decision-making processes regarding intellectual properties of the company.
After completing his degree, he intends to gain more experience in food and drug law as an in-house lawyer or at a law firm. After that, he plans to help small pharmaceutical companies commercialize innovative new drug candidates in the U.S.
Lim is a U.S. attorney admitted to the D.C. Bar.